LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment.
Navarro E, Efthymiou AG, Mattei D, Parks M et al. • Journal of neuroinflammation
(2026)
PMC
PMC Public Access (View-Only)
DOI:
10.1186/s12974-026-03967-0
PMC: PMC13733072